TOPICS

antibody-drug conjugates; anticancer peptides; conjugates for drug delivery; cell-penetrating peptides; cytotoxic peptides;drug targeting; foldamers; integrin ligands; integrin role in cancer; integrins and angiogenesis; integrins and vascular endothelial growth factor receptors; linker technology; multivalency; peptide motifs that inhibit protein-protein interactions; peptide-conjugated nanomaterials; peptide vaccines; peptide hormones; peptide radionuclide carriers; peptide-drug conjugates; peptidomimetics; peptide synthesis; peptide conformations; small molecule-drug conjugates; tumor targeting; targets and specificity; theranostic conjugates